Wed.Sep 07, 2022

article thumbnail

India grants approval for Bharat Biotech’s intranasal Covid-19 vaccine

Pharmaceutical Technology

Indian company Bharat Biotech International has secured approval from Central Drugs Standard Control Organisation (CDSCO) under Restricted Use in Emergency Situation for its intranasal Covid-19 vaccine, iNCOVACC (BBV154), for usage in people aged 18 years and older. A recombinant replication-deficient adenovirus vectored vaccine, iNCOVACC has a prefusion stabilised spike protein and is claimed to be the first intranasal vaccine globally to obtain primary two-dose schedule approvals.

article thumbnail

Roche to pay $250M for Good Therapeutics and its targeted drug technology

Bio Pharma Dive

The team behind the Seattle-based startup will launch a new company, Bonum Therapeutics, after the sale to Roche is completed.

Sales 285
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why We Still Use a 140-Year-Old Method to Diagnose UTIs

AuroBlog - Aurous Healthcare Clinical Trials blog

If you’ve ever had a urinary tract infection (UTI) before, you know what a pain it can be. Not just because of the physical pains it causes, but because it can also be such a pain to go to the doctor, provide a urine sample, and wait for your results. Skip advert UTIs are extremely […].

Doctors 224
article thumbnail

Beam-linked startup launches with an eye on the next generation of RNA drugs

Bio Pharma Dive

“We see a huge opportunity in the setting of RNA-based therapies to overcome some of the shortcomings that have been there with the first generation of RNA companies,” said former Alnylam CEO and Orbital Therapeutics co-founder John Maraganore.

RNA 228
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

Wall Street wants growth, as do investors, but that may be impossible for pharmaceutical companies. In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies. They relied so much on a new drug that they tried to market a product with bad science behind it.

article thumbnail

Can biosimilars, after years of limited impact, finally make a mark in the US?

Bio Pharma Dive

Seven years after the first copycat biologic drug arrived in the U.S., expected cost savings have been modest at best. The next few years will show whether the knockoff drugs can live up to their cut-price promise.

Drugs 177

More Trending

article thumbnail

Backed by Bristol Myers, ArsenalBio raises $220M for its cell therapy research

Bio Pharma Dive

The biotech’s Series B fundraising equips it with new cash just as it prepares to advance its first drug candidate into clinical testing.

Research 183
article thumbnail

Connecting to Purpose: Remembering Mom During Alzheimer’s Awareness Month

Worldwide Clinical Trials

The last time I saw my mom alive, I helped her eat dinner while my son colored her a picture. We were outside, due to Covid-19 restrictions. We were lucky to finally see her in person after almost a year of daily FaceTime videos, and window visits. Of course, none of us knew it would be our last visit. She died on April 3, 2021. My mom was one of the six million Americans living with Alzheimer’s Disease.

article thumbnail

Illumina’s hold on Grail depends now on separate appeals in US, Europe

Bio Pharma Dive

While it plans to appeal this week’s EC decision, Illumina say it’s preparing for ‘strategic alternatives’ to its acquisition of early cancer detection firm Grail.

139
139
article thumbnail

September 7, 2022: This Week’s Grand Rounds Kicks Off Special Series on Ethical and Regulatory Issues in Pragmatic Trials

Rethinking Clinical Trials

Dr. Steven Joffe. In this Friday’s PCT Grand Rounds, Dr. Steve Joffe will kick off our special Grand Rounds series, Ethical & Regulatory Dimensions of Pragmatic Clinical Trials, with a keynote presentation, “Building an Academic Learning Health System: Why Is It So Hard?” The Grand Rounds session will be held on Friday, September 9, 2022, at 1:00 pm eastern.

Trials 130
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

COVID-19 health concern decreased in August: Poll

Pharmaceutical Technology

The health concern over COVID-19 in August 2022 decreased averaging at 22.3%, compared to 27.7% recorded in July 2022 , shows the COVID-19 concern index, which is measured by responses to an ongoing poll Verdict launched in March 2020. The poll has been tracking how the concerns over coronavirus have been changing over time. The poll asked how concerned the respondents were about the spread of coronavirus and included five options to choose from - very concerned, slightly concerned, neither conc

130
130
article thumbnail

Nearly 8 million kids lost a parent or primary caregiver to the pandemic

NPR Health - Shots

A new study finds numbers far higher than previously thought. India has the greatest number of kids affected. The U.S. has 250,000 kids in this category but lags behind in aid for bereaved families.

145
145
article thumbnail

Leading patient adherence pharmaceutical companies

Pharmaceutical Technology

Failing to adhere to prescribed medication regimens is one of the prime reasons for poor patient health outcomes. Pharmaceutical and healthcare companies are working continuously to improve patient adherence, which also impacts disease control and pharmaceutical industry revenues directly. The growing prevalence of chronic diseases and rising geriatric population has led to increasing demand for advanced medication adherence systems, personalised healthcare, and mobile health systems, which are

Pharmacy 130
article thumbnail

The crisis in Jackson shows how climate change is threatening water supplies

NPR Health - Shots

Historic flooding and record droughts are stressing water systems across the country, and experts warn that with climate change intensifying the crisis in Jackson, Miss., may be just the beginning.

145
145
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Diabetic macular oedema market expected to grow to $11.1bn globally by 2031

Pharmaceutical Technology

The diabetic macular oedema (DME) market is anticipated to reach values of $11.1bn in 2031 across the seven major markets (7MM: US, France, Germany, Italy, Spain, UK and Japan). This follows the US Food and Drug Administration's (FDA) recent approval, in January this year, of Roche’s Vabysmo (faricimab) for DME, coupled with the anticipated approval of pipeline therapies in the forecast period from 2021 to 2031, which are expected to drive the growth of the DME market in the 7MM.

Marketing 130
article thumbnail

STAT+: Why Illumina has a merger mess of its own making

STAT News

For Illumina, the leading maker of DNA sequencing equipment, there was bad news and worse news Tuesday. The bad news: The European Commission said it was blocking Illumina’s $8 billion acquisition of Grail, a firm focused on the early detection of cancer. The worse news? In its press release on the ruling, Illumina acknowledged that, although it will appeal, that may not prevent the European Commission from forcing it to divest Grail, which it purchased before regulatory approvals were in

DNA 133
article thumbnail

Leading retail pharmacies in pharma

Pharmaceutical Technology

Increasing diagnosis of chronic diseases is expected to lead to fast growth in retail pharmacies. The rising incidence of long-standing diseases such as hypertension, diabetes, cardiovascular diseases, and cancer requires prolonged medication and, thus, drives the growth and need for retail pharmacies in the market. Pharmacies can cater to the needs of individuals with both complex and relatively simple medical conditions, while some also provide customised and highly personalised care to patien

Pharmacy 147
article thumbnail

As masks are shed, a routine visit to a medical office can pose Covid risks for some patients

STAT News

In May, Sarah Fama had to get blood work done before refilling a prescription for an autoimmune disorder. Because her condition put her at high risk for Covid-19, and she lives with her parents, both in their 80s, she checked the lab’s website, which stated that masks were required inside. When she arrived, she was reassured by a sign on the door that said the same thing.

128
128
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Leading pharmaceutical benefit managers and management companies

Pharmaceutical Technology

Pharmaceutical benefit managers and management companies serve as intermediaries between insurance companies, pharmacies, and drug manufacturers. They bring together employers/plan sponsors, health insurers, plan members, drug wholesalers, pharmacies, and drug companies to facilitate better health outcomes at an affordable cost. Benefit managers are hired by corporate employers, labour unions, health plans, and other institutions to meet their requirements, which is crucial to ensure the success

Pharmacy 130
article thumbnail

Bridge Bio will use Brainomix AI in lung fibrosis trial

pharmaphorum

Brainomix has reeled in another pharma partner for its artificial intelligence-powered biomarker software, used to track the performance of therapeutic interventions in clinical trials. South Korea’s Bridge Biotherapeutics has signed up to use the UK medtech firm’s e-ILD software package in a phase 2 trial of BBT-877, its experimental therapy for serious lung disease idiopathic pulmonary fibrosis (IPF).

Trials 121
article thumbnail

Stress and depression are better long Covid indicators than physical comorbidities, new study says

STAT News

Studies have repeatedly suggested that physical conditions like immunosuppression and hypertension can increase a person’s risk not only for severe Covid but also long Covid. But in a new study , researchers found that psychological stressors such as depression, anxiety, and loneliness were more predictive of Covid patients’ likelihood of experiencing long Covid than classically associated physical factors.

Scientist 116
article thumbnail

Starbucks Names Laxman Narasimhan as New CEO

XTalks

Starbucks has appointed longtime Reckitt CEO and PepsiCo executive Laxman Narasimhan as their new CEO beginning October 1, 2022 after relocating from London to the Seattle area. Until then, he will work closely with interim CEO, Howard Schultz, through April 1, 2023. Here’s what you need to know about Laxman Narasimhan and what he should be prioritizing in his new role.

Branding 105
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Judge invalidates parts of the ACA that mandate health coverage of many preventive services and drugs

STAT News

A federal judge in Texas has ruled that parts of the Affordable Care Act mandating health insurance companies cover many preventive services and drugs for free are unconstitutional. Judge Reed O’Connor also said the ACA’s requirement that health plans cover HIV pre-exposure prophylaxis, or PrEP, at no cost violates religious freedom law.

Drugs 111
article thumbnail

Despite its innocently furry appearance, the puss caterpillar's sting is brutal

NPR Health - Shots

The puss caterpillar has venomous barbs along its hairy body, and they cause extreme pain for many people who come into contact with one of the fuzzy little bugs.

110
110
article thumbnail

Roche pays $250 million to acquire Good Therapeutics and its preclinical cancer therapy

STAT News

Good Therapeutics, a private company that raised just $30 million in venture financing since its 2016 foundation, said Wednesday it had signed a deal to sell itself to Roche for $250 million without ever running a clinical trial. The deal provides a roughly eight-fold return for Good’s investors, which included Codon Capital and RiverVest Venture Partners.

article thumbnail

Amputation in a 31,000-year-old skeleton may be a sign of prehistoric medical advances

NPR Health - Shots

The skeleton of a young adult found in a cave in Indonesia that is missing its left foot and part of its left leg reveal the oldest known evidence of an amputation, according to a new study.

105
105
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Prehistoric skeleton reveals oldest surgical amputation — in a hunter-gatherer society 31,000 years ago

STAT News

The amputation happened when the individual was perhaps 12 years old, the skeleton indicates. Gone is the lower portion of the left leg. And somehow, the individual survived the surgical procedure — a remarkable feat given that it happened some 31,000 years ago. The skeleton, discovered in a cave on Borneo, in what is now Indonesia, appears to be evidence of the oldest known surgical amputation — 24,000 years earlier than that of a farmer in France, who had his left arm cut off an

Research 105
article thumbnail

Juul will pay nearly $440 million to settle states' investigation into teen vaping

NPR Health - Shots

The electronic cigarette maker has agreed to settle a two-year investigation by 33 states and Puerto Rico into the marketing of its vaping products, which have been blamed for a surge in teen vaping.

article thumbnail

STAT+: Tobacco giant Philip Morris is investing billions in health care. Critics say it’s peddling cures for its own poison

STAT News

A new health care company was quietly incorporated last month, with plans to leverage cutting-edge inhalation technology and oral delivery expertise to treat everything from neurology to cardiovascular emergencies. The multibillion-dollar company, Vectura Fertin Pharma , stands out not simply for its ambitions, but because of its financial backer: Philip Morris International, the tobacco behemoth whose cigarettes are sold in more than 180 countries.

105
105
article thumbnail

The new COVID booster could be the last you'll need for a year, federal officials say

NPR Health - Shots

The COVID-19 vaccine strategy may be shifting toward Americans getting yearly vaccinations, like many do with annual flu shots.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.